Tag Archives: AWKNF

Can Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find Out

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:AWKNF), a biotech company developing psychedelic medicines for addiction, has received approval to launch a human study looking into the effects of ketamine in gambling addiction.

The early-stage study will analyze if ketamine administration can modify reward memories associated with gambling, and if successful, will serve as the basis for possible clinical trials using the same method in improving gambling addiction.

While Awakn has begun recruiting human participants, this study is not a clinical trial, explained Prof. Celia....More>>>